Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8969420 Treatment of pervasive developmental disorders with redox-active therapeutics

Patent 8969420 was granted and assigned to Edison Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like US Patent 8969420 Treatment of pervasive developmental disorders with redox-active therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo